Edwards Lifesciences Reaches Analyst Target Price
June 13, 2018 at 07:44 AM EDT
In recent trading, shares of Edwards Lifesciences Corp (EW) have crossed above the average analyst 12-month target price of $148.00, changing hands for $148.52/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..